These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 24847876)

  • 1. Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing.
    Hovestadt V; Jones DT; Picelli S; Wang W; Kool M; Northcott PA; Sultan M; Stachurski K; Ryzhova M; Warnatz HJ; Ralser M; Brun S; Bunt J; Jäger N; Kleinheinz K; Erkek S; Weber UD; Bartholomae CC; von Kalle C; Lawerenz C; Eils J; Koster J; Versteeg R; Milde T; Witt O; Schmidt S; Wolf S; Pietsch T; Rutkowski S; Scheurlen W; Taylor MD; Brors B; Felsberg J; Reifenberger G; Borkhardt A; Lehrach H; Wechsler-Reya RJ; Eils R; Yaspo ML; Landgraf P; Korshunov A; Zapatka M; Radlwimmer B; Pfister SM; Lichter P
    Nature; 2014 Jun; 510(7506):537-41. PubMed ID: 24847876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting the genomic complexity underlying medulloblastoma.
    Jones DT; Jäger N; Kool M; Zichner T; Hutter B; Sultan M; Cho YJ; Pugh TJ; Hovestadt V; Stütz AM; Rausch T; Warnatz HJ; Ryzhova M; Bender S; Sturm D; Pleier S; Cin H; Pfaff E; Sieber L; Wittmann A; Remke M; Witt H; Hutter S; Tzaridis T; Weischenfeldt J; Raeder B; Avci M; Amstislavskiy V; Zapatka M; Weber UD; Wang Q; Lasitschka B; Bartholomae CC; Schmidt M; von Kalle C; Ast V; Lawerenz C; Eils J; Kabbe R; Benes V; van Sluis P; Koster J; Volckmann R; Shih D; Betts MJ; Russell RB; Coco S; Tonini GP; Schüller U; Hans V; Graf N; Kim YJ; Monoranu C; Roggendorf W; Unterberg A; Herold-Mende C; Milde T; Kulozik AE; von Deimling A; Witt O; Maass E; Rössler J; Ebinger M; Schuhmann MU; Frühwald MC; Hasselblatt M; Jabado N; Rutkowski S; von Bueren AO; Williamson D; Clifford SC; McCabe MG; Collins VP; Wolf S; Wiemann S; Lehrach H; Brors B; Scheurlen W; Felsberg J; Reifenberger G; Northcott PA; Taylor MD; Meyerson M; Pomeroy SL; Yaspo ML; Korbel JO; Korshunov A; Eils R; Pfister SM; Lichter P
    Nature; 2012 Aug; 488(7409):100-5. PubMed ID: 22832583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel mutations target distinct subgroups of medulloblastoma.
    Robinson G; Parker M; Kranenburg TA; Lu C; Chen X; Ding L; Phoenix TN; Hedlund E; Wei L; Zhu X; Chalhoub N; Baker SJ; Huether R; Kriwacki R; Curley N; Thiruvenkatam R; Wang J; Wu G; Rusch M; Hong X; Becksfort J; Gupta P; Ma J; Easton J; Vadodaria B; Onar-Thomas A; Lin T; Li S; Pounds S; Paugh S; Zhao D; Kawauchi D; Roussel MF; Finkelstein D; Ellison DW; Lau CC; Bouffet E; Hassall T; Gururangan S; Cohn R; Fulton RS; Fulton LL; Dooling DJ; Ochoa K; Gajjar A; Mardis ER; Wilson RK; Downing JR; Zhang J; Gilbertson RJ
    Nature; 2012 Aug; 488(7409):43-8. PubMed ID: 22722829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling.
    Lindsey JC; Lusher ME; Anderton JA; Bailey S; Gilbertson RJ; Pearson AD; Ellison DW; Clifford SC
    Carcinogenesis; 2004 May; 25(5):661-8. PubMed ID: 14688019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMARCA4/Brg1 coordinates genetic and epigenetic networks underlying Shh-type medulloblastoma development.
    Shi X; Wang Q; Gu J; Xuan Z; Wu JI
    Oncogene; 2016 Nov; 35(44):5746-5758. PubMed ID: 27065321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global analysis of the medulloblastoma epigenome identifies disease-subgroup-specific inactivation of COL1A2.
    Anderton JA; Lindsey JC; Lusher ME; Gilbertson RJ; Bailey S; Ellison DW; Clifford SC
    Neuro Oncol; 2008 Dec; 10(6):981-94. PubMed ID: 18664619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active medulloblastoma enhancers reveal subgroup-specific cellular origins.
    Lin CY; Erkek S; Tong Y; Yin L; Federation AJ; Zapatka M; Haldipur P; Kawauchi D; Risch T; Warnatz HJ; Worst BC; Ju B; Orr BA; Zeid R; Polaski DR; Segura-Wang M; Waszak SM; Jones DT; Kool M; Hovestadt V; Buchhalter I; Sieber L; Johann P; Chavez L; Gröschel S; Ryzhova M; Korshunov A; Chen W; Chizhikov VV; Millen KJ; Amstislavskiy V; Lehrach H; Yaspo ML; Eils R; Lichter P; Korbel JO; Pfister SM; Bradner JE; Northcott PA
    Nature; 2016 Feb; 530(7588):57-62. PubMed ID: 26814967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
    Holm K; Staaf J; Lauss M; Aine M; Lindgren D; Bendahl PO; Vallon-Christersson J; Barkardottir RB; Höglund M; Borg Å; Jönsson G; Ringnér M
    Breast Cancer Res; 2016 Feb; 18(1):27. PubMed ID: 26923702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromatin accessibility mapping identifies mediators of basal transcription and retinoid-induced repression of OTX2 in medulloblastoma.
    Wortham M; Guo C; Zhang M; Song L; Lee BK; Iyer VR; Furey TS; Crawford GE; Yan H; He Y
    PLoS One; 2014; 9(9):e107156. PubMed ID: 25198066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic deregulation of multiple S100 gene family members by differential hypomethylation and hypermethylation events in medulloblastoma.
    Lindsey JC; Lusher ME; Anderton JA; Gilbertson RJ; Ellison DW; Clifford SC
    Br J Cancer; 2007 Jul; 97(2):267-74. PubMed ID: 17579622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
    Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
    Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OTX2 Activity at Distal Regulatory Elements Shapes the Chromatin Landscape of Group 3 Medulloblastoma.
    Boulay G; Awad ME; Riggi N; Archer TC; Iyer S; Boonseng WE; Rossetti NE; Naigles B; Rengarajan S; Volorio A; Kim JC; Mesirov JP; Tamayo P; Pomeroy SL; Aryee MJ; Rivera MN
    Cancer Discov; 2017 Mar; 7(3):288-301. PubMed ID: 28213356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity.
    Coolen MW; Stirzaker C; Song JZ; Statham AL; Kassir Z; Moreno CS; Young AN; Varma V; Speed TP; Cowley M; Lacaze P; Kaplan W; Robinson MD; Clark SJ
    Nat Cell Biol; 2010 Mar; 12(3):235-46. PubMed ID: 20173741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OTX2 sustains a bivalent-like state of OTX2-bound promoters in medulloblastoma by maintaining their H3K27me3 levels.
    Bunt J; Hasselt NA; Zwijnenburg DA; Koster J; Versteeg R; Kool M
    Acta Neuropathol; 2013 Mar; 125(3):385-94. PubMed ID: 23179372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic regulation in medulloblastoma.
    Yi J; Wu J
    Mol Cell Neurosci; 2018 Mar; 87():65-76. PubMed ID: 29269116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic Drivers in Pediatric Medulloblastoma.
    Roussel MF; Stripay JL
    Cerebellum; 2018 Feb; 17(1):28-36. PubMed ID: 29178021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer.
    Hon GC; Hawkins RD; Caballero OL; Lo C; Lister R; Pelizzola M; Valsesia A; Ye Z; Kuan S; Edsall LE; Camargo AA; Stevenson BJ; Ecker JR; Bafna V; Strausberg RL; Simpson AJ; Ren B
    Genome Res; 2012 Feb; 22(2):246-58. PubMed ID: 22156296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma.
    Andolfo I; Liguori L; De Antonellis P; Cusanelli E; Marinaro F; Pistollato F; Garzia L; De Vita G; Petrosino G; Accordi B; Migliorati R; Basso G; Iolascon A; Cinalli G; Zollo M
    Neuro Oncol; 2012 May; 14(5):596-612. PubMed ID: 22411914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by methyl-CpG binding proteins and histone modifications.
    Müller I; Wischnewski F; Pantel K; Schwarzenbach H
    BMC Cancer; 2010 Jun; 10():297. PubMed ID: 20565761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A CTNNB1-altered medulloblastoma shows the immunophenotypic, DNA methylation and transcriptomic profiles of SHH-activated, and not WNT-activated, medulloblastoma.
    Chiang J; Moreira DC; Pytel NJ; Liu YC; Blackburn PR; Shi Z; Cardenas M; Wheeler DA; Furtado LV
    Neuropathol Appl Neurobiol; 2022 Aug; 48(5):e12815. PubMed ID: 35320876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.